SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kimia Biosciences - Quaterly Results

14 Aug 2025 Evaluate
The revenue for the June 2025 quarter is pegged at Rs. 235.84 millions, about 5.29% up against Rs. 223.99 millions recorded during the year-ago period.Net profit of the cmpany stood at Rs. 6.04 millions for the quarter ended June 2025 a decline of -58.00% from Rs. 14.38 millions  in the same quarter last year.Operating Profit reported a sharp decline to 33.73 millions from 37.89 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 235.84 223.99 5.29 235.84 223.99 5.29 1189.21 1048.77 13.39
Other Income 8.47 0.83 920.48 8.47 0.83 920.48 13.20 16.42 -19.61
PBIDT 33.73 37.89 -10.98 33.73 37.89 -10.98 215.70 11.59 1761.09
Interest 17.47 11.08 57.67 17.47 11.08 57.67 45.57 50.50 -9.76
PBDT 16.26 26.81 -39.35 16.26 26.81 -39.35 170.13 -38.91 -537.24
Depreciation 9.35 8.98 4.12 9.35 8.98 4.12 33.79 32.92 2.64
PBT 6.91 17.83 -61.25 6.91 17.83 -61.25 136.34 -71.83 -289.81
TAX 0.87 3.45 -74.78 0.87 3.45 -74.78 40.22 -18.75 -314.51
Deferred Tax 0.87 0.48 81.25 0.87 0.48 81.25 40.22 -18.75 -314.51
PAT 6.04 14.38 -58.00 6.04 14.38 -58.00 96.12 -53.08 -281.09
Equity 47.31 47.31 0.00 47.31 47.31 0.00 47.31 47.31 0.00
PBIDTM(%) 14.30 16.92 -15.45 14.30 16.92 -15.45 18.14 1.11 1541.31

Kimia Biosciences Share Price

35.73 3.81 (11.94%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×